Bacterium-delivered double cross protection vaccine
A cross-protection and vaccine technology, applied in the field of vaccinology, can solve problems such as cross-protection vaccines, and achieve the effect of protecting infection and simple preparation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0012] 1) Construction of plasmid pEADnaK: Edwardsiella tarda TX1 was used as a template, and F1 / R1 was used as primers for PCR amplification. The PCR conditions were: 94°C for 60s to pre-denature the template DNA, then 94°C for 40s, 51°C for 60s, and 72°C 60s, after 5 cycles, change to 94°C for 40s, 61°C for 60s, 72°C for 60s, and after 25 cycles, extend the reaction at 72°C for 10min. The PCR product was purified with the "Tiangen Biochemical Technology (Beijing) Co., Ltd." DNA product purification kit, and then connected to the carrier pEASY-E2 (purchased from "Beijing Quanshijin Biotechnology Co., Ltd.") at room temperature for 2-4 hours. After the mixture was transformed into Escherichia coli DH5α, it was cultured on LB solid medium containing 100 ug / ml anka penicillin (Ap) for 18 hours, a transformant was picked, and the plasmid was extracted, which was pEADnaK.
[0013] The LB composition is calculated by weight percentage: 1.0% peptone, 0.5% yeast powder, 1.0% sodium c...
Embodiment 2
[0021] Construction of the vaccine: Transform the plasmid pDKS10 into Escherichia coli DH5 according to the Hanahan method (Sambrook and Russell: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press 2001) to obtain strain DH5α / pDKS10; / ml) on the LB medium for 18-24 hours, the plasmid was extracted, and the plasmid was found to be plasmid pDKS10 through sequencing, indicating that the bacterial strain DH5α / pDKS10 did contain pDKS10. Strain DH5α / pDKS10 is a vaccine strain with cross-protection against Edwardsiella lentus and Streptococcus iniae. As a control, the plasmid pBT3 was transformed into Escherichia coli DH5 in the same way to obtain strain DH5α / pBT3, which was the control strain.
Embodiment 3
[0023] Application of the vaccine: Step 1) Preparation of the vaccine preparation solution. The vaccine strain DH5α / pDKS10 obtained above and the control strain DH5α / pBT3 were cultured in LB liquid medium to OD 600 0.8-1, then centrifuge the culture solution (5000g, 4°C, 10min), collect the bacteria, and suspend them in PBS to a final concentration of 1×10 8 cfu / ml is the vaccine preparation solution and control solution.
[0024] Step 2) Vaccination. 120 flounder (each weighing about 12.2g) were randomly divided into 4 groups, 30 in each group. These 4 groups are named A, B, C and D respectively. Each fish in groups A and C was injected intraperitoneally with 100 ul of the vaccine preparation solution in step 1) above, and each fish in groups B and D (control group) was injected intraperitoneally with 100 ul of the control solution in step 1) above.
[0025] Step 3) Preparation of Edwardsiella tarda and Streptococcus iniae suspensions. Cultivate Edwardsiella tarda TX1 an...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com